Section I
491 – 500 of 4726
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Selumetinib Plus Adjuvant Radioactive Iodine in Patients with High-Risk Differentiated Thyroid Cancer : A Phase III, Randomized, Placebo-Controlled Trial (ASTRA)
(
- Contribution to journal › Article
-
Mark
An overview of Clinical Quality Registries (CQRs) on gynecological oncology worldwide
(
- Contribution to journal › Scientific review
-
Mark
Comment on Russo et al. Does Tumor Volume Have a Prognostic Role in Oropharyngeal Squamous Cell Carcinoma? A Systematic Review and Meta-Analysis. Cancers 2022, 14, 2465
(
- Contribution to journal › Letter
-
Mark
Histone lysine demethylase inhibition reprograms prostate cancer metabolism and mechanics
(
- Contribution to journal › Article
-
Mark
Levels of Vitamin D and Expression of the Vitamin D Receptor in Relation to Breast Cancer Risk and Survival
(
- Contribution to journal › Article
-
Mark
Rapid Implementation of Telehealth Video Visits in Cancer Care – The Perspectives of Patients and Healthcare Professionals
(
- Contribution to journal › Article
-
Mark
The Harald Breivik lecture 2022. Pathophysiology in persistent severe pain after groin hernia repair
(
- Contribution to journal › Article
-
Mark
PAM50 subtyping and ROR score add long-term prognostic information in premenopausal breast cancer patients
(
- Contribution to journal › Article
-
Mark
Interaction between blood pressure and genetic risk score for bladder cancer, and risk of urothelial carcinoma in men
(
- Contribution to journal › Article
-
Mark
Real World Evaluation of the Prosigna/PAM50 Test in a Node-Negative Postmenopausal Swedish Population : A Multicenter Study
(
- Contribution to journal › Article